Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

Saved in:

Bibliographic Details
Main Authors:	Long Chang, Wen-Xin Li, Hao Cai, Jian Li, Ming-Hui Duan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Oncology
Subjects:	polycythemia vera pegylated interferon JAK2v617F mutation dose de-escalation strategy hematological and molecular response
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1641150/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study
by: Long Chang, et al.
Published: (2025-05-01)

Study of Patients with Polycythemia Vera in JAK2V617F and Mutated and Unmutated Status along with their Anxiety and Worried Thoughts: A Single-center Experience from Eastern India
by: Rishu Vidhatri, et al.
Published: (2024-12-01)

Polycythemia Vera: New Diagnostic Concept and Its Types
by: AM Kovrigina, et al.
Published: (2016-04-01)

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera
by: Chiho Furuya, et al.
Published: (2024-12-01)

Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone,
by: Beatrice Borsellino, et al.
Published: (2022-06-01)

Screening for Janus kinase-2 exon 12 mutations among Janus kinase-2 V617F-negative polycythemia vera suspected Iraqi patients
by: Mushtaq M. Khazeem, et al.
Published: (2024-12-01)

POLYCYTHEMIA VERA IDENTIFIED IN A PATIENT WITH RESTENOSIS OF THE SUPERFICIAL FEMORAL ARTERY. CLINICAL CASE AND REVIEW OF THE LITERATURE
by: G. Sh. Safuanova, et al.
Published: (2017-05-01)

CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
by: Vincenzo Accurso, et al.
Published: (2020-01-01)

From Diagnosis to Health Practice: Polycythemia Vera. A Literature Review
by: Katarzyna Siekaniec, et al.
Published: (2025-07-01)

Genetic Markers of Hereditary Thrombophilia and Risk of Thrombotic Complications in Patients with Polycythemia Vera
by: DI Shikhbabaeva, et al.
Published: (2017-01-01)

A case of chorea with cognitive impairment associated with polycythemia vera
by: Yu. A. Shpilyukova, et al.
Published: (2023-12-01)

Psychiatric Manifestations in Polycythemia Vera: A Case of Refractory Delirium and Psychosis Responding to Hematological Treatment
by: Yusuf Ezel Yıldırım, et al.
Published: (2025-06-01)

Polycythemia Vera in Pregnancy: A Descriptive Review of the Literature
by: Nicole Xu, et al.
Published: (2023-04-01)

All we know about polycythemia vera: literature review and own experience
by: K. M. Abdulkadyrov, et al.
Published: (2015-10-01)

Janus kinase 2 V617F mutation in an unrelated peripheral blood stem cell donor
by: Shang-Hsien Yang, et al.
Published: (2019-01-01)

How we treat polycythemia vera
by: V. A. Shuvaev, et al.
Published: (2024-01-01)

Masked polycythemia vera manifested by splanchnic venous thrombosis during pregnancy: a clinical case
by: M. Yu. Nadinskaia, et al.
Published: (2022-05-01)

A clinical case of cerebellar ataxia with neuropathy and vestibular areflexia syndrome in the presence of polycythemia vera
by: Sh. M. Safin, et al.
Published: (2019-11-01)

The effect of polycythemia vera on choroidal thickness and retrobulbar blood flow
by: Nihat Aydın, et al.
Published: (2024-02-01)

Diagnosis and Treatment of Polycythemia Vera in Pakistan; Barriers and Possible Solutions
by: Rabab Jafry, et al.
Published: (2025-07-01)

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
by: M B Agarwal, et al.
Published: (2015-01-01)

Masked polycythemia vera in a patient 5 years after gastric bypass surgery: A diagnostic pitfall
by: Daniel Rivera, et al.
Published: (2025-02-01)

Evaluating the impact of polycythemia vera on retinal and optic nerve head microvascularity: An OCTA study
by: Meryem Feyza Cicek, et al.
Published: (2024-11-01)

Toxic encephalopathy in a clinicl case of polycythemia vera
by: P. I. Kuznetsova, et al.
Published: (2020-01-01)

Polycythemia vera with acute coronary syndrome and bleeding as initial presentation: A case report and literature review
by: Rabia Iqbal, MBBS, et al.
Published: (2025-02-01)

Revised myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
by: Mohan B Agarwal, et al.
Published: (2018-01-01)

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
by: Stine Ulrik Mikkelsen, et al.
Published: (2018-08-01)

PROGRESSION OF POLYCYTHEMIA VERA TO ACUTE MYELOID LEUKEMIA FOLLOWING LONG-TERM HYDROXYUREA THERAPY: A CASE STUDY
by: Bengisu Ece Duman, et al.
Published: (2025-07-01)

Myocardial infarction in a young man with ulcerative colitis and polycythemia vera: а case report
by: E. V. Gordeeva, et al.
Published: (2025-05-01)

Cerebrovascular Accident in a Patient with Polycythemia: a Case Report
by: O. M. Drapkina, et al.
Published: (2022-03-01)

Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma
by: Ye T, et al.
Published: (2025-08-01)

About hematopoietic properties of peripheral blood lymphocytes RNA from patients with polycythemia vera and healthy donors
by: A. G. Babaeva, et al.
Published: (2015-06-01)

Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera
by: Albert Qin, et al.
Published: (2025-06-01)

СEREBRAL INFARCTION AS THE FIRST MANIFESTATION OF ERYTHREMIA
by: S. G. Zhdanova, et al.
Published: (2016-03-01)

Characteristic and Complication Patterns of Polycythaemia Vera: A Single Centre Experience
by: Rebin Mustafa Othman, et al.
Published: (2025-06-01)

NEW APPROACHES TO THERAPY OF CLASSICAL PH-NEGATIVE MYELOPROLIFERATIVE DISEASES: THE EXPERIENCE OF EARLY THERAPY WITH CEPEGINTERFERON ALPHA-2B
by: A. S. Polyakov, et al.
Published: (2018-05-01)

Research on the Design and Construction Technology of Double Strand Chain Transmission of Escalator
by: Yao Zhenqun, et al.
Published: (2020-03-01)

Ovarian Hyperthecosis Presenting as Polycythemia
by: Gayatri Jaiswal, MD, et al.
Published: (2025-03-01)

Hydronephrosis-Induced Polycythemia with Low Erythropoietin Level: A Case Report and Literature Review
by: Chia-Cheng Chang, et al.
Published: (2024-12-01)

Polycythemia in Nephrotic Syndrome
by: Anagha Auradkar, et al.
Published: (2025-01-01)